Pfizer Inc.
SITE SPECIFIC HER2 ANTIBODY DRUG CONJUGATES
Last updated:
Abstract:
The present invention provides site specific HER2 antibody drug conjugates and methods for preparing and using the same.
Status:
Application
Type:
Utility
Filling date:
3 Jun 2020
Issue date:
3 Dec 2020